This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Mar 1;181(3):403-404.

doi: 10.1001/jamainternmed.2020.6567.

Variation in Biosimilar Uptake in Europe

Jon Trærup Andersen¹, Thomas Bo Jensen¹

Affiliations

PMID: 33284317
DOI: 10.1001/jamainternmed.2020.6567

Comment

Variation in Biosimilar Uptake in Europe

Jon Trærup Andersen et al. JAMA Intern Med. 2021.

. 2021 Mar 1;181(3):403-404.

doi: 10.1001/jamainternmed.2020.6567.

Authors

Jon Trærup Andersen¹, Thomas Bo Jensen¹

Affiliation

¹ Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.

PMID: 33284317
DOI: 10.1001/jamainternmed.2020.6567

No abstract available

PubMed Disclaimer

Comment in

Variation in Biosimilar Uptake in Europe-Reply.
Chen AJ, Van Nuys K. Chen AJ, et al. JAMA Intern Med. 2021 Mar 1;181(3):404. doi: 10.1001/jamainternmed.2020.6570. JAMA Intern Med. 2021. PMID: 33284319 No abstract available.

Comment on

Uptake of Infliximab Biosimilars Among the Medicare Population.
Chen AJ, Gascue L, Ribero R, Van Nuys K. Chen AJ, et al. JAMA Intern Med. 2020 Sep 1;180(9):1255-1256. doi: 10.1001/jamainternmed.2020.3188. JAMA Intern Med. 2020. PMID: 32702080 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations